Mayne CEO O'Brien , sees the transaction as a validation of the company's growth strategy . " Attracting an offer from a strategic buyer who is active in the US dermatology and women's health markets such as Cosette , reflects the excellent work our teams have been doing ." he said . "Having broadened our portfolio and improved patient access through a refined U.S. channel strategy , we have executed against our corporate against our corporate strategies with precision ." This tells us our new CEO / Board never working in our interest . Method in their madness alright doing some of the seemingly nonsensical decisions mad which helped drive share value down and making sure they stayed down by consolidating them to the extent they did .
- Forums
- ASX - By Stock
- MYX
- Help me understand Mr Chairman
MYX
mayne pharma group limited
Add to My Watchlist
2.31%
!
$5.08

Help me understand Mr Chairman, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
-0.120(2.31%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.19 | $5.19 | $4.97 | $918.5K | 181.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | $5.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.08 | 6898 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | 5.050 |
2 | 10046 | 5.020 |
4 | 8072 | 5.010 |
1 | 8000 | 5.000 |
1 | 2426 | 4.990 |
Price($) | Vol. | No. |
---|---|---|
5.080 | 6898 | 1 |
5.110 | 3026 | 2 |
5.130 | 2426 | 1 |
5.150 | 2426 | 1 |
5.170 | 2891 | 2 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |